跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack
Approved
STANDARD
PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack
Seqirus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f9c51538d7f0e86c
Company
Seqirus Pty Ltd
Type
Standard
Approval Details
Approval Id
f9c51538d7f0e86c
Product Name
PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack
Artg Id
165332
Artg Name
PALEXIA SR tapentadol (as hydrochloride) 50 mg sustained release tablet blister pack
Sponsor
Seqirus Pty Ltd
Company Detail Path
/organization/seqirus-pty-ltd
Artg Date
2011-01-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4bdcfca2622d1af858a5d3a3fc0a8e27.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/9ca78817f17e8afac4448c25c16ba7c2.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f9c51538d7f0e86c
Type
Standard
Back to TGA Approvals